Educate Dialysis Patients on the Pros and Cons of Velphoro

March 2020

Velphoro (vel-FOR-oh, sucroferric oxyhydroxide) will be a new phosphate binder for chronic kidney disease patients on dialysis.

Many dialysis patients start with calcium carbonate (Tums, etc) to lower phosphate...but it sometimes boosts calcium levels too high.

Velphoro is a calcium-free alternative...similar to Renvela (sevelamer carbonate), Renagel (sevelamer hydrochloride), or Fosrenol (lanthanum carbonate).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Infection Control Reinforce Infection Control Measures in Light of Coronavirus
Vitamins & Minerals Share the Latest Answers About Vitamin D
Dyslipidemia Don't Be Too Quick to Jump on the Vascepa Bandwagon
Women's Health Stick With Tried and True Treatments for Menstrual Symptoms
Hypertension Be Ready to Manage Patients With Very High BP
Kidney Disease Educate Dialysis Patients on the Pros and Cons of Velphoro
Osteoarthritis Help Patients Navigate Osteoarthritis Treatments
Testosterone Weigh Risks and Benefits of Testosterone for "Low T"
Medication Errors Prevent Cases of Mistaken Med Identity

Educate Dialysis Patients on the Pros and Cons of Velphoro

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents